Please use this identifier to cite or link to this item: https://erepository.fmesinstitute.org/handle/123456789/1709
Title: FDA Regulation of prescription drugs.
Authors: Gassman, A. L.
Nguyen, C. P.
Joffe, H. V.
Issue Date: 2017
Publisher: New England Journal of Medicine
Citation: Gassman, A. L., Nguyen, C. P., & Joffe, H. V. (2017). FDA Regulation of prescription drugs. New England Journal of Medicine, 376(7), 674–682.
Abstract: Over the past 5 years, the FDA has approved 182 new drugs. This overview explains the FDA’s drug-approval process, including its approach to benefit–risk assessment, drug labeling, risk evaluation and mitigation strategies, and postmarketing surveillance.
URI: https://doi.org/10.1056/NEJMra1602972
https://erepository.fmesinstitute.org/handle/123456789/1709
metadata.fmes.numPages: 674–682
Appears in Collections:Ethics

Files in This Item:
There are no files associated with this item.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.